Fellow Committee
The Fellow Committee helps to develop educational programs geared towards the needs of fellows-in-training during CAHON events and facilitates career planning of the trainees. The committee also helps to promote CAHON membership and applications for CAHON young investigator awards.
Zhengrui Xiao, MD (Chair)
Zhengrui Xiao, MD, is an attending physician at Montefiore Einstein and Assistant Professor at our Albert Einstein College of Medicine. His clinical focus is in benign hematology.
After completing his Bachelor of Medicine in 2014 at Nanjing Medical University in Nanjing, China, Dr. Xiao earned his Master of Medicine in hematology at the same institution in 2016 and completed residency training in hematology. He then came to the United States for postgraduate training, completing an internal medicine internship and residency at Jacobi Medical Center Einstein in 2020, followed by a three-year hematology and oncology fellowship at Montefiore Einstein in 2023.
Dr. Xiao’s research focuses on autoimmune hematology including immune thrombocytopenia, autoimmune hemolytic anemia and thrombotic thrombocytopenic purpura. He has shared his work through peer-reviewed journals, abstracts, and poster and oral presentations.
Dr. Xiao is board certified in Internal Medicine and Hematology. He is a member of the American Society of Hematology and the Chinese American Hematologist and Oncologist Network. In 2022, he received the Abstract Achievement Award from the American Society of Hematology and the Young Investigator Award from the Chinese American Hematologist and Oncologist Network. He was also awarded the Teacher of the Year for the 2023-2024 academic year by the Montefiore Hematology Oncology Fellowship Program.
Chen Zhang, MD (Co-Chair)
Dr. Zhang is an active clinical investigator in hematologic malignancy, especially lymphoma. He graduated from Shanghai Jiao Tong University School of Medicine and completed his Internal Medicine residency training at the University of Miami/JFK Medical Center. He worked as an internist for three years after residency, during which he obtained a master's degree in clinical research at Rush University. Currently, he is a Hematology/Oncology fellow at Rush University Medical Center.
Shortly after starting residency, Dr. Zhang was inspired by Dr. Shachar Peles during his Hem/Onc electives and decided to pursue a career in hematology. His research was published at the ASCO and ASH annual meetings. He currently participates in multiple clinical research projects and focuses on research in lymphoma.
Xiao Hu, MD, MPH
Dr. Hu graduated with honors from Peking Union Medical College in Beijing, China, and received her premedical education at Tsinghua University. Following her medical program, she earned a Master of Public Health in Applied Biostatistics & Epidemiology from Yale University. She then moved to Boston, completing her residency at Tufts Medical Center, where she also stayed for her fellowship training in Hematology and Oncology.
Dr. Hu’s clinical interest is in thoracic oncology, and she has a profound passion for conducting clinical research on early detection of cancer, cancer care disparity, and survivorship in the era of novel therapy in lung cancer. She was selected for the FDA-AACR Educational Fellowship and received the ASCO Conquer Cancer Merit Award and the Natalie V. Zucker Research Center for Women Scholars Award during her training. Her work has been presented at multiple conferences, including ASCO, ASCO Quality Care Symposium, ASH, AACR, and WCLC.
Tien-Chan Hsieh, MD
Dr. Tien-Chan Hsieh is a hematology/oncology fellow at the University of Massachusetts Chan Medical School, conducting research with Dr. Chan Zhou. He earned his M.D. from National Yang Ming Chiao Tung University, completing a rigorous seven-year program in Taiwan. Prior to his fellowship, he served as a visiting scholar in Dr. Amir Goldkorn’s lab at the University of Southern California and subsequently completed his internal medicine residency at Danbury Hospital, a Yale-New Haven affiliated program.
Dr. Hsieh possesses extensive experience in analyzing clinical and multi-omic databases. His research has contributed to the discovery of new regulatory mechanisms in bladder cancer cell plasticity (Lu et al., Cancers, 2022) and identified clinical outcome disparities in blood cancers (Hsieh et al., AJHPM, 2024). Currently, he applies artificial intelligence models to analyze high-throughput sequencing data, aiming to detect novel biomarkers that can advance cancer screening and treatment strategies in blood and lung cancers.
Emily Liang, MD
Dr. Emily Liang is a hematology/oncology fellow at the University of Washington and Fred Hutchinson Cancer Center. She attended medical school at UCLA and completed her internal medicine residency at Stanford University. Her focus is in acute leukemias and cellular therapies, particularly improving the efficacy and toxicity profile of CAR T-cell therapies.
Xiaocao Xu (Haze), MD
Dr. Xiaocao Xu is an alumna of Xiangya School of Medicine in Changsha, Hunan. She first did her postgraduate research training at Yale University and later completed her internal medicine residency at Berkshire Medical Center in Massachusetts. Currently, she is a hematology and oncology fellow at the University of Vermont. Her research interests focus on metabolism and immunotherapy. Dr. Xu loves to connect with current fellows and aspiring fellows at CAHON, helping to foster collaboration and networking.